Lever Bio
Homepage
- Website
- leverbio.com
- Total Funding
- $4.7M
- Last Round
- Extension RoundDec 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Lever Bio is an Italian immuno-oncology biotechnology company developing agents that reprogram the solid-tumor microenvironment. Its approach is intended to improve recruitment, activation, and sustained activity of cytotoxic T lymphocytes against solid tumors. The company works with researchers, universities, and research centers to advance promising drug-development programs toward improved cancer outcomes.
Summary
Lever Bio is a Biotech company. It has raised $4.7M in total across 2 rounds, most recently a Extension Round in Dec 2025. Investors include Claris Ventures, Club degli Investitori and Italian Angels for Growth.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Sign up to see all 2 events
Funding: Seed through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lever-bio"><img src="https://indexed.vc/api/badge/company/lever-bio" alt="Lever Bio on Indexed.vc" width="260" height="76" /></a>